Medicaid Coverage of Medications to Treat Alcohol and Opioid Use Disorders
$12.00 | CEU Hours:4.00 | Intermediate*This course is not approved for NBCC renewal. Please see our NBCC category of courses here.
CEU Course Description
This course describes treatment effectiveness, cost effectiveness, current coverage under each Medicaid program, and examples of innovative financing and delivery models used by states to provide disulfiram, acamprosate, methadone, buprenorphine, buprenorphine-naloxone, and naltrexone to those with alcohol and/or opioid use disorders.
CEU Course Objectives
1. Enumerate the three drugs with the least coverage across Medicaid programs for the purpose of treating opioid addiction and explain why this is seen.
2. Investigate what the scientific research has found for the benefits that medications for alcohol and opioid dependence provide to the client and to the rest of society.
3. Compare and contrast the different medications used for alcohol and opioid dependence and explain how each produces the desired results.
4. Examine the five controlled substance schedules defined under the Controlled Substances Act.
5. Identify who may dispense methadone or buprenorphine to a patient under the direction of the OTP medical director who is certified by SAMHSA and registered with the DEA, as long as the activity is consistent with state law.
Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degree of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff here.